Implementation guide for interoperable medicines

This guidance is under active development by NHS England and content may be added or updated on a regular basis.

Profile: Medication

Additional guidance based on the UKCore Medication resource.

idΣ0..1string
metaΣ0..1Meta
implicitRulesΣ ?!0..1uri
language0..1codeBinding
text0..1Narrative
contained0..*Resource
MedicationTradeFamilyC0..1Extension(CodeableConcept)
modifierExtension?! C0..*Extension
identifierΣ0..*Identifier
codeS Σ1..1CodeableConceptBinding
statusΣ ?!0..1codeBinding
manufacturerΣ C0..1Reference(Organization)
form0..1CodeableConceptBinding
amountΣ C0..1Ratio
id0..1string
extensionC0..*Extension
modifierExtensionΣ ?! C0..*Extension
itemCodeableConceptCodeableConcept
itemReferenceReference(Medication | Substance)
isActive0..1boolean
strengthC0..1Ratio
id0..1string
extensionC0..*Extension
modifierExtensionΣ ?! C0..*Extension
lotNumber0..1string
expirationDate0..1dateTime

Additional Guidance

form (for medication characteristics)

Recent implementations have highlighted the need to identify intended release characteristics such as modified release timing when medicines are prescribed at the moiety (VTM) level. Currently this information is only conveyed as unstructured dosage.text with no clear way to represent it in FHIR/Dose Syntax.

To address this gap, an interim approach has been agreed whereby in addition to the use as defined within the FHIR standard and UKCore implementation, the form element may be used to describe characteristics of the medication where these are not already defined within the dm+d concept. While it is recognised that these characteristics are not technically medication forms, this pragmatic solution enables safe and consistent encoding until a more robust mechanism is available.

A longer-term solution is planned as an extension to the UKCore-Medication profile to support structured medication characteristics, using a preferred binding to a defined list of SNOMED terms.

An example use case is when using a VTM concept and wish to specify modified release characteristics of either 12 or 24 hour.

The following list of SNOMED terms is applicable for medication characteristics using both the interim and longer-term solution(s), providing clearer alignment and reducing the risk of misinterpretation across systems.

SNOMED Code SNOMED Term
9906401000001106 12-hour modified-release dosage form (qualifier value)
9906901000001102 24-hour modified-release dosage form (qualifier value)
9906701000001104 Gastro-resistant dosage form (qualifier value)
737051004 Modified-release (release characteristic)
736849007 Conventional release (release characteristic)
764775005 Conventional release and prolonged-release (release characteristic)
736848004 Delayed-release (release characteristic)
737596001 Dual delayed-release (release characteristic)
737594003 Delayed-release and prolonged-release (release characteristic)
736847009 Prolonged-release (release characteristic)
422059006 Metered-dose inhaler
422197009 Breath-actuated inhaler
9906001000001101 Dry powder inhaler
9906801000001108 Nebuliser

Example

{
    "resourceType": "Medication",
    "id": "UKCore-Medication-Characteristics-Example",
    "code": {
        "coding":  [
            {
                "system": "https://dmd.nhs.uk",
                "code": "773372004",
                "display": "Morphine"
            }
        ]
    },
    "form": {
        "coding":  [
            {
                "system": "http://snomed.info/sct",
                "code": "9906401000001106",
                "display": "12-hour modified-release dosage form (qualifier value)"
            }
        ]
    }
}

back to top